ストックスクリーナーアプリを入手
3.88
1.02%
-0.04
前日終値:
$3.92
開ける：
$3.9
24時間の取引高:
37,271
Relative Volume:
0.20
時価総額：
$20.97M
収益：
$15.00M
当期純損益:
$2.71M
株価収益率:
3.0491
EPS:
1.2725
ネットキャッシュフロー:
$-2.89M
1週間 パフォーマンス:
+6.59%
1か月 パフォーマンス:
-11.21%
6か月 パフォーマンス:
-3.48%
1年 パフォーマンス:
-52.16%
1日の値動き範囲:
$3.8715
$4.00
1週間の範囲:
$3.60
$4.06
52週間の値動き範囲:
$3.19
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Compare NEUP vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
3.88 | 20.81M | 15.00M | 2.71M | -2.89M | 1.2725 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 繰り返されました | Maxim Group | Buy |
| 2022-01-10 | 開始されました | Berenberg | Buy |
| 2022-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 開始されました | Evercore ISI | Outperform |
| 2022-01-10 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Neuphoria Therapeutics Inc (NEUP) 最新ニュース
Halper Sadeh LLC is Investigating Whether SAFT, NEUP, NRIM are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Neuphoria Therapeutics Inc (NEUP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Neuphoria Therapeutics Inc (NEUP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NEUP|Neuphoria Therapeutics Inc|Price:3.970|Chg%:+0.330 - TradingKey
Neuphoria Therapeutics Inc (NEUP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuphoria Therapeutics Inc (NEUP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuphoria Therapeutics Inc (NEUP) Income Statement - TradingKey
NEUP|Neuphoria Therapeutics Inc|Price:3.810|Chg%:+0.170 - TradingKey
Neuphoria Therapeutics Inc (NEUP) Cash Flow - TradingKey
Neuphoria Therapeutics Market Sentiment - Benzinga España
Neuphoria Therapeutics Inc (NASDAQ: NEUP) Share Price, NEUP Stock News, NEUP Share Price & Updates - Kalkine
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Monteverde & Associates investigates Neuphoria Therapeutics merger fairness for shareholders. - Pluang
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Neuphoria Therapeutics, Inc. (NASDAQ: NEUP) - PR Newswire
Neuphoria Therapeutics (NEUP) Proxy filing Summary - Quartr
Neuphoria Therapeutics to Merge with Scancell Holdings - TipRanks
Neuphoria Therapeutics (Nasdaq: NEUP) to be acquired by Scancell - Stock Titan
Neuphoria Therapeutics to Merge With Scancell; Holders to Receive ADSs Plus CVRs - TradingView
Scancell and Neuphoria agree all-share merger supported by up to US$89 million financing - Yahoo Finance UK
Neuphoria agrees to all-share merger with Scancell in deal valuing Neuphoria holders at 14.5% stake - Bitget
NEUPHORIA THERAPEUTICSSCANCELL EXPECTS TO SECURE UP TO $89 MLN IN FINANCING - Moomoo
Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell - Moomoo
Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $34.7 million. - marketscreener.com
Scancell, Neuphoria Therapeutics Agree All-share Merger - Moomoo
Scancell merges with Neuphoria after Merck axes trial; AstraZeneca breast cancer drug approved in EU - Endpoints News
Scancell agrees to buy Neuphoria, combined firm set to list on Nasdaq - marketscreener.com
Scancell And Neuphoria Therapeutics Announce Merger Agreement - TradingView
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing - The Manila Times
Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing - TradingView
Scancell to join Nasdaq through Neuphoria merger and $89 million funding package - Proactive financial news
Scancell Holdings Secures £9 Million via UK Share Placing Ahead of Nasdaq Merger with Neuphoria Therapeutics - Kalkine Media
MRK, NEUP stocks drop as Merck scraps another Alzheimer’s drug trial under Neuphoria partnership - MSN
Price to book forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Enterprise value to revenue forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Price to earnings forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Enterprise value to EBITDA forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Price to sales forward of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
Neuphoria Therapeutics (NEUP) Slips 1.26% as Stock Tests Key Support ZoneVolume Nodes - dars.gov.et
Neuphoria announces initiation of strategic review - MSN
Number of shareholders of Neuphoria Therapeutics Inc. – NASDAQ:NEUP - TradingView
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership - Stocktwits
NEUP Q2 2026 Earnings: Significant EPS Beat Driven by Cost ManagementEarnings Cycle Report - dars.gov.et
NEUPNeuphoria Therapeutics Inc Latest SEC Filings - Finviz
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer's Drug Trial Under Neuphoria Partnership - Mena FN
UK-based Scancell bids to buy Nasdaq-listed Neuphoria to ‘increase profile’ with US investors - Fierce Biotech
Scancell Confirms Advanced Talks for Potential Acquisition of Nasdaq-listed Neuphoria Therapeutics - Moomoo
Neuphoria confirms merger talks with Scancell Holdings - Investing.com UK
Neuphoria confirms merger talks with Scancell Holdings By Investing.com - Investing.com Nigeria
Neuphoria Therapeutics (NEUP) Confirms Acquisition Talks with Sc - GuruFocus
Neuphoria Therapeutics Inc's stock price recorded a significant increase of 6% in after-hours trading, closing at $4.85. - Bitget
Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell - TradingView
Neuphoria Therapeutics Inc (NEUP) 財務データ
収益
当期純利益
現金流量
EPS
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):